Researchers from the convergence environment ImmunoLingo win Idéprisen 2022
Inven2's Idépris 2022 goes to a virtual tool for developing antibodies. The idea was developed by Victor Greiff, head of the convergence environment ImmunoLingo, together with colleagues from the University of Oslo and Oslo University Hospital.